Partner Content Partner Content This Week's Spotlight Features GSK and Advanced Cell Diagnos... RNA Therapeutics Feb 2018
Partner Content Partner Content STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics STORM Therapeutics Exclusive Speaker Interview
Partner Content Partner Content STORM Therapeutics Announces Publication in Nature on RNA Ep... RNA Therapeutics
Partner Content Partner Content The first patient to be injected with an RNA based anti-canc... RNA Therapeutics
Partner Content Partner Content Topics Presented this February 2018 at RNA Therapeutics RNA Therapeutics
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
